Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHACKO JOSE ALAPPATT

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1477584399
CMS profile
202838
Location
MIAMISBURG, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$13,660.31

136 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 136 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHACKO JOSE ALAPPATT

NPI 1477584399 · CMS profile ID 202838

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

MIAMISBURG, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 136 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1477584399?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHACKO JOSE ALAPPATT, NPI 1477584399, CMS profile ID 202838. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 136 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1477584399?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). CHACKO JOSE ALAPPATT, NPI 1477584399, CMS profile ID 202838. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 136 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1477584399?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
CHACKO JOSE ALAPPATT, NPI 1477584399, CMS profile ID 202838, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 136 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1477584399?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

136 matching records · $13,660.31 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 136 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 136.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
UCB, Inc. $5.4408/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965184055 CMS
Janssen Biotech, Inc. $2.7108/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886365965 CMS
Radius Health, Inc. $15.7508/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954963035 CMS
PFIZER INC. $11.8008/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949225443 CMS
Horizon Therapeutics plc $124.5208/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937583719 CMS
Horizon Therapeutics plc $2,448.0008/18/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937583723 CMS
PFIZER INC. $12.9908/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949242829 CMS
Amgen Inc. $15.8608/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939167281 CMS
Genentech USA, Inc. $27.4808/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950699009 CMS
Janssen Biotech, Inc. $3.5908/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886365959 CMS
ABBVIE INC. $18.2108/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890478235 CMS
AstraZeneca Pharmaceuticals LP $22.9208/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915733049 CMS
Horizon Therapeutics plc $17.7308/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937583715 CMS
Horizon Therapeutics plc $800.0008/03/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937583710 CMS
Amgen Inc. $8.0007/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939822041 CMS
ABBVIE INC. $16.9307/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890478233 CMS
UCB, Inc. $5.6007/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965184059 CMS
UCB, Inc. $925.0007/25/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965184075 CMS
UCB, Inc. $23.8907/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 907977221 CMS
ABBVIE INC. $8.6107/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890478231 CMS
GlaxoSmithKline, LLC. $17.1007/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944684019 CMS
ABBVIE INC. $14.2407/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890478229 CMS
ABBVIE INC. $1.8307/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890478227 CMS
ABBVIE INC. $11.8006/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890478225 CMS
Mallinckrodt Hospital Products Inc. $26.4206/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937469329 CMS
Janssen Biotech, Inc. $27.9706/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886366007 CMS
Exeltis, USA Inc. $12.4706/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947105559 CMS
Amgen Inc. $10.3406/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939167275 CMS
UCB, Inc. $17.8706/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965177097 CMS
ABBVIE INC. $9.3406/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890478223 CMS
Oxford Immunotec USA Inc $19.7006/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 952859921 CMS
Genentech USA, Inc. $24.9206/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950773535 CMS
Radius Health, Inc. $20.3206/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954962955 CMS
UCB, Inc. $725.0006/07/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038607853 CMS
ABBVIE INC. $2.0106/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890478219 CMS
ABBVIE INC. $13.5406/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890478221 CMS
Amgen Inc. $20.5306/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939167261 CMS
Organon LLC $13.2105/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946436767 CMS
ABBVIE INC. $11.3105/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890478217 CMS
Janssen Biotech, Inc. $5.2905/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886366001 CMS
ABBVIE INC. $1.4605/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890478213 CMS
ABBVIE INC. $0.8605/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890478215 CMS
AstraZeneca Pharmaceuticals LP $16.6105/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915621793 CMS
Amgen Inc. $10.2005/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939822037 CMS
Horizon Therapeutics plc $4.3205/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937583705 CMS
Amgen Inc. $11.7405/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939167271 CMS
ABBVIE INC. $16.2505/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890478211 CMS
ABBVIE INC. $8.4405/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890478209 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.3505/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887785525 CMS
Amgen Inc. $3.6804/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939167279 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $81,356.85 266
PY2020 $55,960.32 277
PY2021 $40,114.05 185
PY2022 $13,660.31 136
PY2023 $10,438.00 172
PY2024 $22,367.20 171
PY2025 $33,855.13 207

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $486,480.02 12
PY2024 Principal investigator $253,145.87 27
PY2023 Principal investigator $96,999.41 27
PY2022 Principal investigator $125,965.15 44
PY2021 Principal investigator $336,623.58 23
PY2020 Principal investigator $190,370.49 25
PY2019 Principal investigator $215,499.65 7

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $491.00 12/17/2025 Non-covered Recipient Entity
Premier Clinic Rsrch
A Study of Guselkumab in Participants With Active Psoriatic Arthritis (APEX) No dispute reported 06/30/2026 1175261753
Principal investigator 1 Amgen Inc. $7,016.76 08/08/2025 Non-covered Recipient Entity
ARTHRITIS & OSTEOPOROSIS CENTER OF SOUTHWEST OHIO - MIAMISBURG
A Multicenter, Open-Label, Long-term, Extension Study to Evaluate the Safety and Tolerability of Dazodalibep in Participants With Sjgren's Syndrome (SS) No dispute reported 06/30/2026 1246639383
Principal investigator 1 Amgen Inc. $8,845.00 08/01/2025 Non-covered Recipient Entity
PREMIER CLINICAL RESEARCH, INC.
A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Participants With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis No dispute reported 06/30/2026 1246646732
Principal investigator 1 Amgen Inc. $1,237.47 07/28/2025 Non-covered Recipient Entity
ARTHRITIS-OSTEOPOROSIS CENTER
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgren's Syndrome With Moderate-to-severe Systemic Disease Activity No dispute reported 06/30/2026 1246639417
Principal investigator 1 Amgen Inc. $21,803.27 05/23/2025 Non-covered Recipient Entity
PREMIER CLINICAL RESEARCH LLC
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgren's Syndrome With Moderate-to-severe Systemic Disease Activity No dispute reported 06/30/2026 1246646712
Principal investigator 1 Amgen Inc. $29,764.03 05/21/2025 Non-covered Recipient Entity
PREMIER CLINICAL RESEARCH, INC.
A Multicenter, Open-Label, Long-term, Extension Study to Evaluate the Safety and Tolerability of Dazodalibep in Participants With Sjgren's Syndrome (SS) No dispute reported 06/30/2026 1246646720
Principal investigator 1 Amgen Inc. $51,612.70 04/09/2025 Non-covered Recipient Entity
PREMIER CLINICAL RESEARCH, INC.
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgren's Syndrome With Moderate-to-severe Systemic Disease Activity No dispute reported 06/30/2026 1246646728
Principal investigator 1 UCB SA $17,447.00 04/09/2025 Non-covered Recipient Entity
PREMIER CLINICAL RESEARCH
A Multicenter, Randomized, Double-Blind, Risankizumab-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants with Active Psoriatic Arthritis. No dispute reported 06/30/2026 1246659410
Principal investigator 1 Amgen Inc. $45,840.06 03/03/2025 Non-covered Recipient Entity
ARTHRITIS & OSTEOPOROSIS CENTER OF SOUTHWEST OHIO - MIAMISBURG
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgrens Syndrome With Moderate-to-Severe Systemic Disease Activity No dispute reported 06/30/2026 1246639385
Principal investigator 1 Amgen Inc. $255,061.15 01/30/2025 Non-covered Recipient Entity
STAT RESEARCH
A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Participants With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis No dispute reported 06/30/2026 1246648713
Principal investigator 1 Amgen Inc. $12,931.16 01/06/2025 Non-covered Recipient Entity
CLINICAL RESEARCH OF WEST FLORIDA INC- CLEARWATER
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgren's Syndrome With Moderate-to-severe Systemic Disease Activity No dispute reported 06/30/2026 1246640335
Principal investigator 1 Amgen Inc. $34,430.42 01/03/2025 Non-covered Recipient Entity
ARTHRITIS & OSTEOPOROSIS CENTER OF SOUTHWEST OHIO - MIAMISBURG
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgren's Syndrome With Moderate-to-severe Systemic Disease Activity No dispute reported 06/30/2026 1246639387